2,5b,9,9,11a-pentamethyl-2,3,4,5,5a,5b,6,9,9a,10,11,11a-dodecahydro-1,12-dioxatetraphene-4,6-dione is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.
Customer service consultation
Pack Size
Price
USA Stock
Global Stock
Quantity
1 mg
Inquiry
35 days
35 days
2 mg
Inquiry
35 days
35 days
3 mg
Inquiry
35 days
35 days
4 mg
Inquiry
35 days
35 days
5 mg
Inquiry
35 days
35 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
2,5b,9,9,11a-pentamethyl-2,3,4,5,5a,5b,6,9,9a,10,11,11a-dodecahydro-1,12-dioxatetraphene-4,6-dione is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature.
Calculator
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 10%DMSO+ 40%PEG300+ 5%Tween 80+ 45%Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μLDMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μLPEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μLTween 80 and mix well until fully clarified.
3) Add 450 μLSaline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Preview
Related Tags: 2,5b,9,9,11a-pentamethyl-2,3,4,5,5a,5b,6,9,9a,10,11,11a-dodecahydro-1,12-dioxatetraphene-4,6-dione chemical structure | 2,5b,9,9,11a-pentamethyl-2,3,4,5,5a,5b,6,9,9a,10,11,11a-dodecahydro-1,12-dioxatetraphene-4,6-dione formula | 2,5b,9,9,11a-pentamethyl-2,3,4,5,5a,5b,6,9,9a,10,11,11a-dodecahydro-1,12-dioxatetraphene-4,6-dione molecular weight